Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Cerus Corporation

CERSNASDAQ
Healthcare
Medical - Devices
$1.69
$-0.01(-0.59%)
U.S. Market opens in 14h 53m

Cerus Corporation Fundamental Analysis

Cerus Corporation (CERS) shows moderate financial fundamentals with a PE ratio of -20.55, profit margin of -7.58%, and ROE of -26.42%. The company generates $0.2B in annual revenue with strong year-over-year growth of 15.29%.

Key Strengths

Cash Position25.73%
PEG Ratio-7.80
Current Ratio1.73

Areas of Concern

ROE-26.42%
Operating Margin-4.21%
We analyze CERS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3.3/100

We analyze CERS's fundamental strength across five key dimensions:

Efficiency Score

Weak

CERS struggles to generate sufficient returns from assets.

ROA > 10%
-7.04%

Valuation Score

Excellent

CERS trades at attractive valuation levels.

PE < 25
-20.55
PEG Ratio < 2
-7.80

Growth Score

Excellent

CERS delivers strong and consistent growth momentum.

Revenue Growth > 5%
15.29%
EPS Growth > 10%
47.62%

Financial Health Score

Moderate

CERS shows balanced financial health with some risks.

Debt/Equity < 1
1.51
Current Ratio > 1
1.73

Profitability Score

Weak

CERS struggles to sustain strong margins.

ROE > 15%
-2641.85%
Net Margin ≥ 15%
-7.58%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CERS Expensive or Cheap?

P/E Ratio

CERS trades at -20.55 times earnings. This suggests potential undervaluation.

-20.55

PEG Ratio

When adjusting for growth, CERS's PEG of -7.80 indicates potential undervaluation.

-7.80

Price to Book

The market values Cerus Corporation at 5.00 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.00

EV/EBITDA

Enterprise value stands at -32.63 times EBITDA. This is generally considered low.

-32.63

How Well Does CERS Make Money?

Net Profit Margin

For every $100 in sales, Cerus Corporation keeps $-7.58 as profit after all expenses.

-7.58%

Operating Margin

Core operations generate -4.21 in profit for every $100 in revenue, before interest and taxes.

-4.21%

ROE

Management delivers $-26.42 in profit for every $100 of shareholder equity.

-26.42%

ROA

Cerus Corporation generates $-7.04 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.04%

Following the Money - Real Cash Generation

Operating Cash Flow

Cerus Corporation generates limited operating cash flow of $4.88M, signaling weaker underlying cash strength.

$4.88M

Free Cash Flow

Cerus Corporation generates weak or negative free cash flow of $1.12M, restricting financial flexibility.

$1.12M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CERS converts 0.34% of its market value into free cash.

0.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-20.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-7.80

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.000

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.57

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.51

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.26

vs 25 benchmark

ROA

Return on assets percentage

-0.07

vs 25 benchmark

ROCE

Return on capital employed

-0.07

vs 25 benchmark

How CERS Stacks Against Its Sector Peers

MetricCERS ValueSector AveragePerformance
P/E Ratio-20.5528.25 Better (Cheaper)
ROE-26.42%780.00% Weak
Net Margin-7.58%-20122.00% (disorted) Weak
Debt/Equity1.510.30 Weak (High Leverage)
Current Ratio1.734.66 Neutral
ROA-7.04%-14687.00% (disorted) Weak

CERS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cerus Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

82.96%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

77.76%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

113.07%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ